Activity value 90brazil Buyer&Supplier,Last transaction date:
2026-03-31Address: brasil,sao paulo, br,rua raposo tavares nr.2833 km 30.5
Overview
Contact
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for blau farmaceutica s.a. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 8 transactions, with a transaction quantity of 69327.9 and a transaction weight of 4901.21.
YearTransactionsQuantityWeight
2025101799177100954.08
2026869327.94901.21
Bill of lading data
<
1/15
>
Trade date
2026/03/31
B/L No.
——
Suppliers
blau farmaceutica s.a.
Buyers
centro medico amanecer s.r.l.
Product description
PRODUCTOS FARMACEUTICOS SANGRE HUMANA, SANGRE ANIMAL PREPARADA PARA USOS TERAPEUTICOS, PROFILACTICOS O DE DIAGNOSTICO, ANTISUEROS (SUERO CON ANTICUERPOS), DEMAS FRACCIONES DE LA SANGRE, Y PRODUCTOS INMUNOLOGICOS MODIFICADOS, INCLUSO OBTENIDOS POR PROCESOS
Expand
Trade date
2026/03/31
B/L No.
——
Suppliers
blau farmaceutica s.a.
Buyers
centro medico amanecer s.r.l.
Product description
PRODUCTOS FARMACEUTICOS SANGRE HUMANA, SANGRE ANIMAL PREPARADA PARA USOS TERAPEUTICOS, PROFILACTICOS O DE DIAGNOSTICO, ANTISUEROS (SUERO CON ANTICUERPOS), DEMAS FRACCIONES DE LA SANGRE, Y PRODUCTOS INMUNOLOGICOS MODIFICADOS, INCLUSO OBTENIDOS POR PROCESOS
Expand
Trade date
2026/03/18
B/L No.
——
Suppliers
blau farmaceutica s.a.
Buyers
centro medico amanecer s.r.l.
Product description
PRODUCTOS FARMACEUTICOS SANGRE HUMANA, SANGRE ANIMAL PREPARADA PARA USOS TERAPEUTICOS, PROFILACTICOS O DE DIAGNOSTICO, ANTISUEROS (SUERO CON ANTICUERPOS), DEMAS FRACCIONES DE LA SANGRE, Y PRODUCTOS INMUNOLOGICOS MODIFICADOS, INCLUSO OBTENIDOS POR PROCESOS
Expand
Trade date
2026/03/18
B/L No.
——
Suppliers
blau farmaceutica s.a.
Buyers
centro medico amanecer s.r.l.
Product description
PRODUCTOS FARMACEUTICOS SANGRE HUMANA, SANGRE ANIMAL PREPARADA PARA USOS TERAPEUTICOS, PROFILACTICOS O DE DIAGNOSTICO, ANTISUEROS (SUERO CON ANTICUERPOS), DEMAS FRACCIONES DE LA SANGRE, Y PRODUCTOS INMUNOLOGICOS MODIFICADOS, INCLUSO OBTENIDOS POR PROCESOS
Expand
Product description
PRODUCTOS FARMACEUTICOS MEDICAMENTOS (EXCEPTO LOS PRODUCTOS DE LAS PARTIDAS 30.02, 30.05 O 30.06) CONSTITUIDOS POR PRODUCTOS MEZCLADOS O SIN MEZCLAR, PREPARADOS PARA USOS TERAPEUTICOS O PROFILACTICOS, DOSIFICADOS (INCLUIDOS LOS ADMINISTRADOS POR VIA TRANS
Expand
blau farmaceutica s.a. is brazil Buyer&Supplier,
and primarily engages in the import and export business of products such as equipped with fixed dose drug,medicament,immunological products.
According to the 52wmb.com global trade database, as of 2026-03-31, the company has completed 3996 international trades,
with its main trading regions covering colombia,paraguay,peru etc.
The core products include HS3004902900,HS3004321900,HS3002159000 etc,
often transported via guarulhos,port vcp-sao paulo-viracopos airport, port sao paulo etc,
and its main trading partners are blau farmaceutica colombia s.a.s.,laboratorios sumimed ltd.,centro medico amanecer s.r.l..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on blau farmaceutica s.a. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.